Synthesis of novel heterocyclic compounds containing pyrimidine nucleus using the Biginelli reaction: Antiproliferative activity and docking studies

ArticleAçık Erişim

Özet

In a single reaction step, pyrimidine derivatives (4a-p) were synthesized from the triple reaction of aromatic aldehydes (1), ethyl cyanoacetate (2), and some guanyl hydrazone derivatives (3a-n). These compounds were tested as in vitro against two types of cancerous cell lines, namely, a human colon cancerous cell line (DLD-1) and a human breast cancerous cell line (MDA-MB-231). According to the obtained results, nearly all the compounds have cytotoxic activity in the tested cell lines. Especially, the compounds 4j, 4k, and 4n had a significant effect against DLD-1. Furthermore, compounds 4g, 4m, and 4o exhibited lower IC50 values compared to other synthesized compounds against MDA-MB-231. We hope that these compounds can be improved as anticancer agents in the future. Molecular docking was performed according to both topoisomerase I and N-acetyltransferase 1 proteins to examine theoretically the binding mode and site of pyrimidine compounds having the best activity. © 2020 Wiley Periodicals, Inc.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13890Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/jhet.3978Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorÇağlar Yavuz, Sevtap
dc.contributor.authorAkkoç, Senem
dc.contributor.authorTürkmenoğlu, Burçin
dc.contributor.authorSarıpınar, Emin
dc.date.accessioned2026-10-18T20:28:41.595500051Z
dc.date.available2026-10-18T20:28:41.595500051Z
dc.date.issued2020
dc.description.abstractIn a single reaction step, pyrimidine derivatives (4a-p) were synthesized from the triple reaction of aromatic aldehydes (1), ethyl cyanoacetate (2), and some guanyl hydrazone derivatives (3a-n). These compounds were tested as in vitro against two types of cancerous cell lines, namely, a human colon cancerous cell line (DLD-1) and a human breast cancerous cell line (MDA-MB-231). According to the obtained results, nearly all the compounds have cytotoxic activity in the tested cell lines. Especially, the compounds 4j, 4k, and 4n had a significant effect against DLD-1. Furthermore, compounds 4g, 4m, and 4o exhibited lower IC50 values compared to other synthesized compounds against MDA-MB-231. We hope that these compounds can be improved as anticancer agents in the future. Molecular docking was performed according to both topoisomerase I and N-acetyltransferase 1 proteins to examine theoretically the binding mode and site of pyrimidine compounds having the best activity. © 2020 Wiley Periodicals, Inc.
dc.description.sponsorshipFunding text 1: This work was financially supported by the Research Fund of Erciyes Üniversitesi [FDK‐2016‐6664]. We would like to thank the Genome and Stem Cell Center (GENKÖK) for their assistance. We are also thankful to Prof Dr Mustafa Çetin for donating two positive control drugs. ; Funding text 2: Research Fund of Erciyes University, Grant/Award Number: FDK‐2016‐6664 Funding information ; Funding text 3: This work was financially supported by the Research Fund of Erciyes Üniversitesi [FDK-2016-6664]. We would like to thank the Genome and Stem Cell Center (GENKÖK) for their assistance. We are also thankful to Prof Dr Mustafa Çetin for donating two positive control drugs.
dc.identifier.doi10.1002/jhet.3978
dc.identifier.eissn1943-5193
dc.identifier.endpage2627
dc.identifier.issn0022-152X
dc.identifier.issue6
dc.identifier.scopus2-s2.0-85084668055
dc.identifier.startpage2615
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13890
dc.identifier.volume57
dc.identifier.wosWOS:000523636700001
dc.language.isoen
dc.publisherHeteroCorporation
dc.relation.ispartofJournal of Heterocyclic Chemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject2 [2 [(2 chloro 6 fluorophenyl)methylidene] hydrazino] 4 hydroxy 6 phenylpyrimidine 5 carbonitrile
dc.subject2 [2 [(2,4 dimethoxyphenyl)methylidene]hydrazino] 4 hydroxy 6 phenyl 1,6 dihydropyrimidine 5 carbonitrile
dc.subject4 hydroxy 2 [2 [1 (4 methoxyphenyl)ethylidene] hydrazino] 6 phenylpyrimidine 5 carbonitrile
dc.subject4 hydroxy 6 (4 methylphenyl) 2 [2 [(4 methyl phenyl) methylidene]hydrazino]pyrimidine 5 carbonitrile
dc.subject4 hydroxy 6 phenyl 2 [2 (1 phenylethylidene) hydrazino]pyrimidine 5 carbonitrile
dc.subjectheterocyclic compound
dc.subjectn [[4 [(5 cyano 4 hydroxy 6 phenylpyrimidin 2 yl) hydrazono]methyl]phenyl]acetamide
dc.subjectpyrimidine derivative
dc.subjectunclassified drug
dc.subjectantiproliferative activity
dc.subjectArticle
dc.subjectBiginelli reaction
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectDLD-1 cell line
dc.subjectdrug synthesis
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC50
dc.subjectMDA-MB-231 cell line
dc.subjectmolecular docking
dc.titleSynthesis of novel heterocyclic compounds containing pyrimidine nucleus using the Biginelli reaction: Antiproliferative activity and docking studies
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus21
rdl.citation.wos20
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)
rdl.wos.indexIndex Chemicus (IC)